Literature DB >> 7783244

Beyond controlling blood pressure in the black patient: metabolic considerations.

J F Burris1.   

Abstract

Hypertension is highly prevalent among African Americans, who are also more likely than whites to develop end-organ complications of hypertension. Traditional diuretic-based stepcare therapy has successfully reduced such complications of hypertension as stroke, congestive heart failure, and premature death in all populations tested. Prevention of coronary deaths has been less successful. Potentially adverse metabolic effects of thiazide diuretics and some beta-blockers may partially explain the less successful cardiac outcomes. Use of antihypertensive agents lacking adverse metabolic effects but still achieving effective blood pressure control could improve cardiac outcomes while maintaining the benefits achieved with older forms of therapy. Achievement of improved cardiac outcomes is now one of the principal goals of hypertension research and treatment.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7783244      PMCID: PMC2607791     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  7 in total

Review 1.  Critique of the clinical importance of diurectic-induced hypokalemia and elevated cholesterol level.

Authors:  E D Freis
Journal:  Arch Intern Med       Date:  1989-12

Review 2.  Beta-blockers, dyslipidemia, and coronary artery disease. A reassessment.

Authors:  J F Burris
Journal:  Arch Intern Med       Date:  1993-09-27

3.  A comparison of the efficacy and safety of a beta-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks.

Authors:  E Saunders; M R Weir; B W Kong; J Hollifield; J Gray; V Vertes; J R Sowers; M B Zemel; C Curry; J Schoenberger
Journal:  Arch Intern Med       Date:  1990-08

4.  Diuretic therapy for hypertension and the risk of primary cardiac arrest.

Authors:  D S Siscovick; T E Raghunathan; B M Psaty; T D Koepsell; K G Wicklund; X Lin; L Cobb; P M Rautaharju; M K Copass; E H Wagner
Journal:  N Engl J Med       Date:  1994-06-30       Impact factor: 91.245

5.  Benefits and potential harm of lowering high blood pressure.

Authors:  J M Cruickshank; J M Thorp; F J Zacharias
Journal:  Lancet       Date:  1987-03-14       Impact factor: 79.321

Review 6.  Effects of doxazosin on serum lipids: a review of the clinical data and molecular basis for altered lipid metabolism.

Authors:  J L Pool
Journal:  Am Heart J       Date:  1991-01       Impact factor: 4.749

Review 7.  Hypertension in elderly patients.

Authors:  W B Applegate
Journal:  Ann Intern Med       Date:  1989-06-01       Impact factor: 25.391

  7 in total
  1 in total

Review 1.  Adverse metabolic effects of antihypertensive drugs. Implications for treatment.

Authors:  H G Preuss; J F Burris
Journal:  Drug Saf       Date:  1996-06       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.